Compare with uniQure N.V.



Key facts today


uniQure (QURE) and the FDA aligned on key parts of a confirmatory gene therapy trial. The randomized study will enroll about 200 patients, with screening in the U.S. expected to start by end-2026. 1
Analyze the impactAnalyze the impact
Market capitalization
‪1.59 B‬ USDSmall cap
−4.05 USD
‪−198.97 M‬ USD
‪16.10 M‬ USD
‪64.46 M‬
Beta (1Y)
3.67
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
Employees (FY)
221
Change (1Y)
+12+5.74%
Revenue / Employee (1Y)
‪72.84 K‬ USD
Net income / Employee (1Y)
‪−900.32 K‬ USD

Company info


CEO
Matthew C. Kapusta
Headquarters
Amsterdam
Founded
1998
IPO date
Feb 5, 2014
ISIN
NL0010696654
FIGI
BBG005SSJYH3
Identifiers
ISIN NL0010696654
CFI code
ESVUFX
uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
Neutral
Neutral
An aggregate view of professional's ratings.
Neutral
Neutral
Neutral
Displays a symbol's price movements over previous years to identify recurring trends.
Weight0.47%
Market value‪49.42 M‬
Weight0.11%
Market value‪11.87 M‬
Weight0.10%
Market value‪9.53 M‬
Weight0.04%
Market value‪8.42 M‬
Weight0.02%
Market value‪3.81 M‬
Weight1.07%
Market value‪3.07 M‬
Weight1.02%
Market value‪2.68 M‬
Weight0.47%
Market value‪2.01 M‬
Weight0.10%
Market value‪1.36 M‬
Weight0.10%
Market value‪1.36 M‬

Explore more ETFs 

Frequently asked questions


uniQure N.V. is scheduled to release its next earnings report on Nov 4, 2026.

Why it matters:
– Key event: Earnings often drive significant price moves
– Market expectations: Traders watch revenue, EPS, and guidance vs forecasts
– Volatility spike: Price swings can increase before and after the release

How to use it:
– Track upcoming reports in the Earnings Calendar
– Compare actual results with analyst estimates
– Monitor price reaction and volume on Supercharts
QURE stock is 5.36% volatile and has beta coefficient of 3.67.

What it means:
– Volatility: Shows how much the price fluctuates over time
– Beta > 1: More volatile than the market
– Beta < 1: Less volatile, more stable

Important to know:
– Volatility can increase during earnings, news events, or market stress
– Large-cap stocks like QURE are typically less volatile than smaller companies

Track every detail on uniQure N.V. stock chart and check out the list of the most volatile stocks — is uniQure N.V. there?
To understand the QURE stock performance, it's worth checking price changes for various periods to get the full picture:
– 1 day — +3.92%
– 1 week — +9.70%
– 1 month — +0.63%

QURE all-time low was 3.73 USD (Jul 5, 2024), and its highest price is 82.49 USD (Jun 20, 2019). Find more dynamics in the Stock Heatmap and on the uniQure N.V. stock chart.
uniQure N.V. market capitalization is ‪1.59 B‬, representing the total value of all its outstanding shares (price × shares outstanding).

What it means:
– Market cap is one of the key ways to classify companies (large-cap, mid-cap, etc.)
– It reflects how investors value the company today
– It changes constantly with stock price movements

What to look at next:
– Market cap trends: Rising cap may signal growth and investor confidence; falling cap can reflect risk or downturns
– Price vs shares: Changes can come from uniQure N.V. stock price moves or share count (buybacks, issuance)
– Valuation ratios: Compare market cap with revenue and earnings
– Peer comparison: See how uniQure N.V. stacks up against other companies
The safest way to buy uniQure N.V. stocks is through a reliable broker. Create an account, fund it, and place a buy order.

You can trade QURE directly from TradingView:
– Choose a broker: Explore our supported trading partners and pick one that fits your needs
– Compare options: View available brokers side by side to evaluate fees and features
– Connect your account: Open Supercharts, click “Trade”, select your broker, and log in
– Start trading: Place orders without leaving the chart

Tip: If you’re new to trading, try paper trading first — it lets you practice strategies in real market conditions without risking funds.
As of Nov 4, 2026, the company has 221 employees.

Why traders follow this data:
– Company scale: Employee count reflects the size and global reach of the business
– Operational footprint: Higher headcount often indicates broader product lines, retail presence, or services
– Trend signal: Changes over time can reflect hiring growth, restructuring, or efficiency improvements

See our rating of the largest employers to find more opportunities.
Investing in uniQure N.V. depends on your goals, risk tolerance, and market conditions. It’s essential to analyze the stock before making a decision.

First, study uniQure N.V. financials and track their dynamics on the Fundamental Graphs:
– Business fundamentals: Revenue, earnings, and growth trends
– Valuation: P/E ratio, market cap, and how it compares to peers
– Profitability: Margins, return on equity, and cash flow
– Dividends (if any): Yield, payout ratio, and consistency

Then explore our QURE technicals – signals based on essential indicators calculations:
– Today — sell
– 1-week — sell
– 1-month — sell

Combine fundamental and technical analysis for better results.
uniQure N.V. stock ticker depends on the exchange where it’s listed. On the NASDAQ, its primary exchange, uniQure N.V. stocks trade under the symbol QURE.

About tickers:
– Unique identifiers: A ticker is a short code used to find and trade a stock
– Exchange-specific: The same company may have different tickers across exchanges
– Search shortcut: Used on trading platforms, charts, and screeners

Remember:
– Some companies have multiple listings
– Always check the exchange prefix to avoid confusion

Learn how to find your desired assets in our Symbol Search.
QURE earnings for the last quarter are −1.22 USD per share, whereas the estimation was −0.82 USD, resulting in a −48.37% surprise. The estimated earnings for the next quarter are −0.92 USD per share.

How to read financials:
– Compare actual vs estimates: Earnings beats or misses often drive price moves
– Watch market reaction: Price response matters as much as the numbers
– Look at forward guidance: Future estimates signal expected growth
– Track trends: Analyze results across multiple quarters, not just one

Follow other essential metrics in uniQure N.V. financials:
– Revenue growth: Shows business expansion
– Margins (operating, net): Reflect profitability and efficiency
– Free cash flow: Indicates real cash generation
– Debt levels: Impacts financial stability and risk
uniQure N.V. revenue for the last quarter amounts to ‪5.84 M‬ USD despite the estimated figure of ‪5.45 M‬ USD. In the next quarter revenue is expected to reach ‪6.17 M‬ USD.

How to read this data:
– Compare actual vs estimates: Revenue beats or misses can move the stock
– Watch market reaction: Price response shows how investors interpret results
– Look at growth: Compare with previous quarters and year-over-year data
– Track trends: One quarter matters less than consistent performance

Follow other essential metrics in uniQure N.V. financials:
– Earnings (EPS): Profitability per share
– Margins (gross, operating): Efficiency and cost control
– Free cash flow: Cash available after expenses
Yes, you can track uniQure N.V. financials in yearly and quarterly reports right on TradingView.

Use our Earnings Calendar to never miss important releases and spot opportunities early.
QURE net income for the last quarter is ‪−81.06 M‬ USD, while the quarter before that showed ‪−53.53 M‬ USD of net income which accounts for −51.41% change.

How to read this data:
– Track changes: Compare net income across quarters to spot trends
– Watch expectations: Compare with estimates to gauge performance
– Check margins: Net income reflects profitability after all expenses
– Look beyond one quarter: Consistency matters more than a single result

Follow other essential metrics in uniQure N.V. financials:
– Revenue: Overall business growth
– Earnings per share: Rising EPS over time often points to improving business performance
– Margins (gross, operating): Efficiency and cost control
No, uniQure N.V. does not currently pay dividends to its shareholders.

Instead of distributing profits as cash payments, the company may choose to reinvest earnings back into the business — for example, in growth, innovation, acquisitions, or debt reduction.

What to consider instead:
– Earnings growth: Is the company increasing profitability over time?
– Revenue expansion: Is the business scaling its operations?
– Free cash flow: Does it generate enough cash to potentially support future dividends?
– Share buybacks: Some companies return capital through repurchasing shares instead of dividends
QURE reached its all-time high of 82.49 USD on Jun 20, 2019. Its all-time low was 3.73 USD and was reached on Jul 5, 2024.

Explore the uniQure N.V. stock price chart to see more price history, and discover companies reaching new all-time highs and lows.
uniQure N.V. EBITDA is ‪−189.65 M‬ USD, with an EBITDA margin of ‪−1.06 K‬%.

EBITDA is a measure of core operating performance, showing how much profit the company generates from its main business activities before accounting for financing and accounting-related costs.

What it means:
– Operating strength: Helps assess profitability from core operations
– Efficiency signal: Rising EBITDA often reflects improving business performance
– Comparability: Useful for comparing companies with different capital structures

What to look at next in uniQure N.V. statements:
– Revenue growth: Shows whether the business is expanding
– Net income: Captures full profitability after all expenses
– Free cash flow: Shows actual cash generated
– Debt levels: Important when evaluating earnings quality
Analyst forecasts suggest a price range between 28.00 USD and 95.00 USD for QURE, based on current estimates.

Remember:
– Forecasts show possible scenarios, not guaranteed outcomes
– They're based on multiple analysts’ models and assumptions
– Target prices change with earnings, news, and market conditions

Don't rely on analysts' opinions alone:
– Use technical analysis: Trend, support/resistance, momentum
– Study fundamentals: Revenue, earnings, margins
– Account for market context: News, macro trends, sector performance